Scarica l'app Stockscreener
17.30
2.31%
0.445
Precedente Chiudi:
$16.86
Aprire:
$16.96
Volume 24 ore:
10,750
Relative Volume:
0.21
Capitalizzazione di mercato:
$331.49M
Reddito:
$54,000
Utile/perdita netta:
$-210.26M
Rapporto P/E:
-21.91
EPS:
-0.79
Flusso di cassa netto:
$-159.01M
1 W Prestazione:
-5.53%
1M Prestazione:
+31.38%
6M Prestazione:
+87.99%
1 anno Prestazione:
-26.28%
Intervallo 1D:
$16.96
$17.68
Intervallo di 1 settimana:
$15.68
$19.45
Portata 52W:
$7.65
$30.00
Lyell Immunopharma Inc Stock (LYEL) Company Profile
Nome
Lyell Immunopharma Inc
Settore
Industria
Telefono
650 695-0677
Indirizzo
201 HASKINS WAY, SOUTH SAN FRANCISCO
Confronta LYEL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LYEL
Lyell Immunopharma Inc
|
17.25 | 323.90M | 54,000 | -210.26M | -159.01M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
410.37 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
473.76 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.47 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
817.35 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
316.39 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Lyell Immunopharma Inc Stock (LYEL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-30 | Downgrade | BofA Securities | Buy → Underperform |
| 2024-06-27 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2023-08-28 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-11-14 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-11-11 | Downgrade | Goldman | Buy → Neutral |
| 2022-10-17 | Iniziato | H.C. Wainwright | Buy |
| 2021-07-12 | Iniziato | BofA Securities | Buy |
| 2021-07-12 | Iniziato | Goldman | Buy |
| 2021-07-12 | Iniziato | JP Morgan | Overweight |
| 2021-07-12 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Lyell Immunopharma Inc Borsa (LYEL) Ultime notizie
Analyzing Lyell Immunopharma Inc. with risk reward ratio chartsWeekly Stock Summary & Safe Entry Zone Identification - newser.com
Can momentum traders help lift Lyell Immunopharma Inc.2025 Market Trends & Detailed Earnings Play Alerts - newser.com
How to track smart money flows in Lyell Immunopharma Inc.Portfolio Return Report & Weekly Breakout Stock Alerts - newser.com
Historical volatility pattern of Lyell Immunopharma Inc. visualizedMarket Trend Summary & Risk Controlled Daily Trade Plans - newser.com
Is it too late to sell Lyell Immunopharma Inc.Trade Analysis Report & Verified Entry Point Signals - newser.com
Tick level data insight on Lyell Immunopharma Inc. volatilityPortfolio Value Report & Free Safe Entry Trade Signal Reports - newser.com
Is Lyell Immunopharma Inc. showing signs of accumulationMarket Movement Recap & Expert Curated Trade Setup Alerts - newser.com
Is Lyell Immunopharma Inc. forming a reversal pattern2025 Market WrapUp & Long-Term Capital Growth Strategies - newser.com
Lyell Immunopharma (NASDAQ:LYEL) Receives "Sell (D-)" Rating from Weiss Ratings - MarketBeat
Will Lyell Immunopharma Inc. continue its uptrend2025 Market Outlook & Risk Managed Investment Signals - newser.com
Clarius Group LLC Reduces Stake in Lyell Immunopharma, Inc. $LYEL - MarketBeat
Can trapped investors hope for a rebound in Lyell Immunopharma Inc.Long Setup & Technical Pattern Alert System - newser.com
Johnson & Johnson Reduces Stock Holdings in Lyell Immunopharma, Inc. $LYEL - MarketBeat
Smart tools for monitoring Lyell Immunopharma Inc.’s price actionPortfolio Update Summary & Long-Term Safe Investment Plans - newser.com
News impact scoring models applied to Lyell Immunopharma Inc.July 2025 Fed Impact & Technical Buy Zone Confirmations - newser.com
Technical analysis overview for Lyell Immunopharma Inc. stockGlobal Markets & High Conviction Trade Alerts - newser.com
Trend analysis for Lyell Immunopharma Inc. this weekProduct Launch & Free Community Supported Trade Ideas - newser.com
Applying chart zones and confluence areas to Lyell Immunopharma Inc.Earnings Overview Report & Capital Efficiency Focused Strategies - newser.com
Will Lyell Immunopharma Inc. stock deliver long term returns2025 Earnings Impact & High Accuracy Investment Signals - newser.com
Using Ichimoku Cloud for Lyell Immunopharma Inc. technicals2025 Stock Rankings & Community Trade Idea Sharing Platform - newser.com
How moving averages guide Lyell Immunopharma Inc. tradingPortfolio Growth Summary & High Accuracy Swing Entry Alerts - newser.com
Voya Investment Management LLC Sells 2,606 Shares of Lyell Immunopharma, Inc. $LYEL - Defense World
Applying Elliott Wave Theory to Lyell Immunopharma Inc.Market Risk Analysis & Consistent Profit Trading Strategies - newser.com
Goldman Sachs Group Inc. Has $193,000 Position in Lyell Immunopharma, Inc. $LYEL - Defense World
What’s the recovery path for long term holders of Lyell Immunopharma Inc.Weekly Loss Report & Consistent Return Investment Signals - newser.com
Lyell Immunopharma Inc Azioni (LYEL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.01%
0.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):